SCHEMBL4389709

SCHEMBL4389709

CC(OC(=O)Cc1ccccc1)OC(=O)C(CCCCCCCC(=O)O)C(C)OC(=O)Cc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.48
MAPT P10636 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
PAM P19021 1/20 0.40
FAAH O00519 3/20 0.38
MAPK1 P28482 2/20 0.38
ALDH1A1 P00352 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
TBXAS1 P24557 1/20 0.38
ATM Q13315 1/20 0.36
HDAC3 O15379 2/20 0.36
HDAC4 P56524 2/20 0.36
HDAC1 Q13547 2/20 0.36
HDAC7 Q8WUI4 2/20 0.36
HDAC2 Q92769 2/20 0.36
HDAC10 Q969S8 2/20 0.36
HDAC11 Q96DB2 2/20 0.36
HDAC8 Q9BY41 2/20 0.36
HDAC6 Q9UBN7 2/20 0.36
HDAC9 Q9UKV0 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4381334 1.00 TSHR (0.48) TSHRMAPTRXFP1PAMFAAH
SCHEMBL4389944 1.00 TSHR (0.48) TSHRMAPTRXFP1PAMFAAH
SCHEMBL4388775 1.00 TSHR (0.48) TSHRMAPTRXFP1PAMFAAH
SCHEMBL4389690 1.00 TSHR (0.48) TSHRMAPTRXFP1PAMFAAH
SCHEMBL4390818 0.99 TSHR (0.49) TSHRMAPTRXFP1PAMFAAH
SCHEMBL4388755 0.95 TSHR (0.50) TSHRMAPTRXFP1PAMFAAH
SCHEMBL3834720 0.84 TSHR (0.59) TSHRMAPTRXFP1PAMFAAH
SCHEMBL4393835 0.83 HTT (0.41) TSHRMAPTRXFP1ALDH1A1HTT
SCHEMBL4397152 0.83 HTT (0.41) TSHRMAPTRXFP1ALDH1A1HTT
SCHEMBL4383967 0.83 HTT (0.41) TSHRMAPTRXFP1ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7629383-B2 Double esters DRUG DISCOVERY LABORATORY AS (NO) 2009-12-08 US disclosed
US-20050203181-A1 Double esters DRUG DISCOVERY LABORATORY AS (NO) 2005-09-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050203181-A1 Double esters ACACA, CES1, ACACB TSHR 1933/4885MAPT 4589/4885RXFP1 4035/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.